ASCO GU 2024

ASCO GU 2026: Treatment Intensification and Real-World Outcomes in Advanced Prostate CancerSent on 03 March 2026

ASCO GU 2026 Prostate: Genomic Testing, AI Insights + Patient-Centered CareSent on 01 March 2026

ASCO GU 2026 Optimizing PSMA-Targeted Strategies in Advanced Prostate CancerSent on 28 February 2026

ASCO GU 2026 Late-Breaking Phase 3 Data in Renal Cell CarcinomaSent on 28 February 2026

NMIBC Focus + MIBC Bladder Sparing: ASCO GU 2026 Bladder HighlightsSent on 28 February 2026

ASCO GU 2026 Systemic Strategies and Treatment Optimization in Prostate CancerSent on 27 February 2026

ASCO GU Advances Across Urothelial CarcinomaSent on 27 February 2026

ASCO GU 2026 Prostate Cancer: Updates on Treatment Selection and MonitoringSent on 26 February 2026

ASCO GU 2026 Preview + Coverage Begins ThursdaySent on 24 February 2026

Real-World Insights on Bladder Cancer Treatment TrendsSent on 21 February 2025

Driving Science to Improve Patient-Centered Care, Advances in Prostate Cancer at ASCO GU 2025Sent on 20 February 2025

ASCO GU 2025: NMIBC Advances, ADC Innovations & Real-World DataSent on 19 February 2025

How Radioligand Therapy Is Shaping Advanced Prostate Cancer Treatment – ASCO GU 2025Sent on 18 February 2025

ASCO GU 2025: Key Updates and Insights in Renal Cell Carcinoma ResearchSent on 16 February 2025

Bladder Cancer ASCO GU 2025: Treatment Sequencing, Biomarkers & Novel TherapiesSent on 15 February 2025

Advancing Renal Cell Carcinoma Imaging & Treatment – ASCO GU 2025Sent on 15 February 2025

Bladder Cancer Breakthroughs & Emerging Strategies - ASCO GU 2025Sent on 15 February 2025

ASCO GU 2025 Advancing Treatment Strategies in Bladder Cancer Across Disease StagesSent on 14 February 2025

ASCO GU 2025 Treatment Intensification, Radiopharmaceuticals, and Real-World Evidence in Prostate CancerSent on 14 February 2025

ASCO GU 2025 Prostate Cancer Day 1 Highlights: Treatment, Imaging & BiomarkersSent on 13 February 2025

Written Coverage Starts Thursday Feb 13th - Join Us for ASCO GU 2025!Sent on 11 February 2025

The Intersection of Climate Change and CancerSent on 06 July 2024

ASCO24 Highlights: Advanced Prostate Cancer - Treatment Strategies & BiomarkersSent on 06 June 2024

Recap of GU Oncology Highlights, Prostate, Bladder, and Renal: ASCO GU 2024 Sent on 31 January 2024

Imaging, Therapeutics and Collaboration in Care for Prostate Cancer Patients: ASCO GU 2024 Sent on 30 January 2024

Highlights in NMIBC and Advanced Urothelial Carcinoma from ASCO GU 2024 Sent on 29 January 2024

Ablative Radiotherapy, Antibody-Radioisotopes, Patient Reported Outcomes and Novel Methods of Administration in Renal Cell Carcinoma: ASCO GU 2024 Sent on 28 January 2024

Trial Results Lead to New Considerations for Patient Management in Renal Cell Carcinoma: ASCO GU 2024Sent on 28 January 2024

Management and Treatment Modalities Give Hope for Patients with Bladder Cancer: ASCO GU 2024 Sent on 27 January 2024

Approaches to Improving Bladder Cancer Management: ASCO GU 2024 Sent on 26 January 2024

Emerging Evidence in Localized and Recurrent Prostate Cancer: Genomic Insights, Novel Therapeutics, and Enhanced Detection Strategies ASCO GU 2024 Sent on 26 January 2024

Highlights from ASCO GU 2024 on Prostate Cancer Treatment ModalitiesSent on 25 January 2024

Breakthrough Trial Highlights in Prostate Cancer from ASCO GU Day OneSent on 25 January 2024

Join UroToday at ASCO GU 2024 for Conference Coverage Written by Clinicians for CliniciansSent on 18 January 2024

Display #
Results 1 - 34 out of 34